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It is well established that the tumor microenvironment 
(TME) actively participates in fundamental processes such 
as tumor initiation, invasion and response to therapies, apart 
from its documented scaffold role. Ultimately, the TME 
can be defined as a tri-dimensional network structured by 
the tumor-associated extra-cellular matrix (ECM) in which 
tumor cells interact with various types of stromal cells in an 
attempt to hijack the normal organization of the host tissue 
and support cancer growth.
The TME has various aptitudes that can induce both 
beneficial and adverse consequences for tumorigenesis. 
Microenvironment components can use different way 
to influence the behavior of tumor cells including: (I) 
signaling induced by ECM components at the tumor cells’ 
surface; (II) remodeling of the extracellular matrix (1); (III) 
signal transmission through cytokines secretion (2); (IV) 
modulation of tumor cell signaling and gene expression via 
extracellular vesicles (EVs) content (3).
Among the components of the TME, fibroblasts represent 
the main cellular type, while the latest evidence suggests 
that the key communication option for cancer-associated 
fibroblasts (CAFs) is mediated via exosomes secretion (4).
Exosomes are defined as lipoprotein shells that contain 
lipids, proteins and nucleic acids [mRNA, microRNAs 
(miRNAs)] with a diameter ranging between 20 and 
120 nm (4). Exosomes can carry their content from one 
cell to another for far distances, mainly through blood, 
protecting it from the degrading activity of extracellular 
enzymes and then allow the emitting cell to directly 
influence the recipient cell. Their production and secretion 
is increased in cancer cells compared to normal cells. 
In addition, their molecular composition is very wide, 
and could be significantly vary depending on cell type, 
conditions (pH, hypoxia) and treatment; for these reasons, 
their role in the TME has been recently considered. 
Regarding the proteomic content of exosomes, recent 
studies have reported that exosomes containing amphiregulin 
can contribute to cancer invasion and metastasis in colorectal 
cancer (5). Metalloproteases, proteins able to degrade 
extracellular matrix proteins, can also be incorporated within 
exosomes and correlate with cancer invasion. Exosomes from 
leukemic and glioblastoma cells have been shown to increase 
endothelial cells’ tube formation and vascularization by 
increasing angiogenesis through their cargo proteins (6,7).
Despite the importance of the proteomic content of 
exosomes, the significance of miRNAs as components of 
exosomes has also been investigated and linked to various 
diseases including cancer. miRNAs exist organically as the 
most biologically stable nucleic acid comprising 19–23 
nucleotides that can act as post-transcriptional modulators 
of gene expression via miRNA-mRNA interactions. 
The majority of published papers report the effects of 
miRNAs on tumor cells, but another interesting point 
of view suggests that they can be involved in fibroblasts 
transformation into CAFs. Currently, several studies have 
suggested exosome-mediated miRNAs transduction plays 
a pivotal role in the crosstalk between tumors cells and the 
TME. Thus, it has been recently demonstrated that tumor 
cell derived-exosomal miR-9 is able to promote fibroblasts 
motility and transformation into CAFs, enhancing breast 
cancer invasion (8). Moreover, overexpression of miR-21 
has been implicated in different tumor types including lung, 
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ovarian, breast, colon, gastric, glioblastoma and pancreatic. 
miR-21 is one of the most abundant miRNAs in exosomes 
and is considered to be an oncogene, as it promotes tumor 
cell proliferation, migration, and invasiveness by targeting 
a number of tumor-suppressor genes and exhibiting 
proangiogenic properties (9). Due to its upregulation in 
cancers and oncogenic properties, miR-21 plasma levels 
have been used as markers for several tumors types (10) 
(Figure 1).
Au Yeung et al. (11) have shown that miR-21, transferred 
via exosomal vesicles from CAFs and cancer associated 
adipocytes, can confer chemoresistance to ovarian cancer 
cells by modulating the apoptotic protease-activating 
factor 1 (APAF1) and the formation of apoptosome while 
interfering with the recruitment and activation of cell-
killing caspases, a mechanism that has already been related 
with drug resistance (12).
This work highlighted the pivotal role of interactions 
between tumor cells and cancer-associated cells in the TME 
to support invasion and resistance to therapies. On the 
other hand, the authors used type I collagen matrix to study 
the invasion of cancer cells transfected or not with miR21. 
Unfortunately, those cancer cells have not been co-cultured 
with CAFs or adipocytes, which would have allowed the 
study of cancer cells interactions with stromal counterparts 
in a tridimensional matrix. An in vivo mouse model was 
used instead, where cancer cells have been co-injected with 
mouse embryonic fibroblasts. In this setting TME cannot 
be directly manipulated and, consequently, intercellular 
relationship between tumor and stromal cells cannot be 
clearly assessed. 
An in vivo mouse model was used instead, allowing the 
authors to translate their results to a model incorporating 
the TME. Mouse embryonic fibroblasts have been used 
in this in vivo model to study the CAF/ovarian cancels 
interactions, even if the authors observed the highest 
amount of miR21 in CAA-derived exosomes. Deciphering 
CAA/ovarian cancer cells interactions via exosomes would 
actually help to understand the set-up of the premetastatic 
niche in which tumor cells-derived exosomes play an 
important role (13). Thus, it would be also interesting to 
describe changes in the content and amount of exosomes 
produced by CAA and CAF in response to paclitaxel.
Interestingly, it has been demonstrated that miR-21 is 
able to promote prostate cell neoplastic transformation 
while in clear-cell renal carcinoma it acts as an oncogenic 
factor by increasing cell proliferation and epithelial-
mesenchymal transition (14,15). The effects of miR-21 
transported in CAF exosomes on normal ovarian cells have 
not been tested. It would be interesting to asses if miR-21 
could drive a possible CAF mediate tumorigenesis. These 
additional data would provide a complete framework of the 
consequences of chemotherapies on TME, shedding light 
on the origins of tumor resistance to treatments (Table 1).
Overall miRNAs appear to represent one of the most 
powerful content of exosomes, particularly of those secreted 
Figure 1 Schematic representation of cancer-associated fibroblast (CAF) secreted exosomes and their effects on cancer cells. CAFs can 
influence tumor cells by different mechanisms. Exosomes secretion is currently considered as the main machinery used by CAFs to influence 
tumor cells behavior. Exosomes from CAFs can transport proteins, mRNAs, and miRNAs, transfer of these molecules can lead to increased 
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by TME. Interestingly, miR-21 is not the only miRNA that 
has been associated with chemoresistance either positively or 
negatively. miR-645 has been involved in cisplatin-induced 
apoptosis in osteosarcoma (16), while miR-196a-5p has 
been shown to have a role in bladder cancer gentamicine-
mediated apoptosis (17). miR-221 has been associated in 
5-FU resistance of esophageal adenocarcinoma (18). An 
important role in cell cycle control of pituitary cells is played 
by miR-26a and related pathways (19). miR-122 derived 
from cancer exosomes, has been shown to be able to enhance 
energetic metabolism and to increase cancer progression (20). 
miRNAs found in exosomes have not only been related 
to chemoresistance but also with other crucial physio/
pathologic processes: miR-15-16 expression has been found 
in exosomes from different type of vascular cells, displaying 
antiangiogenic activity targeting VEGF-A, while miR-200 
family has been associated with cell adhesion (8).
The influence of TME and the mechanism behind it 
have opened a new path to be considered in drug design 
and tumor treatment. Stroma cell types in the TME are 
relatively stable particularly when compared to tumor cells, 
and for this reason they are currently a putative therapeutic 
target which can reduce the risk of resistance and tumor 
recurrence. The increasing knowledge of TME/miRNA/
exosomes systems and tumor/TME cross-talk will hopefully 
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